SUN PHARMACEUTICAL INDUSTRIES LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,523 INR | +0.42% |
|
-1.12% | +20.91% |
Business Summary
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Number of employees: 41,000
Sales per Business
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 384,264 | 100.0 % | 432,789 | 100.0 % | +12.63% |
Sales per region
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
India
32.7
%
| 134,439 | 35.0 % | 141,624 | 32.7 % | +5.34% |
United States
32.3
%
| 117,344 | 30.5 % | 139,704 | 32.3 % | +19.06% |
Emerging Markets
19.8
%
| 72,757 | 18.9 % | 85,633 | 19.8 % | +17.70% |
Rest of the World
15.2
%
| 59,726 | 15.5 % | 65,827 | 15.2 % | +10.22% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Founder | 68 | 81-12-31 | |
| Director of Finance/CFO | - | 17-06-18 | |
Anil Rao
CTO | Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Anoop Deshpande
CMP | Compliance Officer | - | 21-03-31 |
Nimish Desai
IRC | Investor Relations Contact | - | - |
Suresh Kumar Rai
HRO | Human Resources Officer | - | Dec. 06 |
S. Damodharan
PRN | Corporate Officer/Principal | - | - |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 07-03-31 |
| Corporate Officer/Principal | 65 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 68 | 81-12-31 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21-05-20 |
Rolf K. Hoffmann
BRD | Director/Board Member | 63 | 23-06-14 |
Aalok Shanghvi
BRD | Director/Board Member | - | - |
| Director/Board Member | 67 | 93-12-31 | |
| Director/Board Member | 60 | 22-10-31 | |
| Director/Board Member | 71 | 18-05-24 | |
| Director/Board Member | 68 | 21-05-20 | |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 07-03-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 2,399,334,970 | 1,087,065,568 ( 45.31 %) | 0 | 45.31 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
| 29,497,813 | 78.48% | 1,248,937,402 $ | |
SCPHARMACEUTICALS INC. 6.01% | 2,167,679 | 6.01% | 10,881,749 $ |
Company contact information
Sun Pharmaceutical Industries Ltd.
CTS No. 201 B/1, Sun House Western Express Highway
400063, Mumbai
+91 22 4324 4324
http://www.sunpharma.com
Group companies
| Name | Category and Sector |
|---|---|
Basics GmbH
 Basics GmbH Medical DistributorsDistribution Services Part of Sun Pharmaceutical Industries Ltd., Basics GmbH is a pharmaceutical company based in Leverkusen, DE. The CEO of the private company is Hellen de Kloet. The German company distributes high-quality and medically recognized prescription drugs, covering a wide range of therapeutic indications with their generics. For more information, healthcare professionals can log in with their access data on the company's website. The company's contact information is available on their website for customer service and orders. |
Medical Distributors
|
Sun Pharma (Netherlands) BV
 Sun Pharma (Netherlands) BV Drugstore ChainsRetail Trade Sun Pharma (Netherlands) BV engages in the sale and distribution of generic medicine. The company is headquartered in Hoofddorp, the Netherlands. |
Drugstore Chains
|
Sun Pharma Distributors Ltd.
| |
Sun Pharma Laboratories Ltd.
 Sun Pharma Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Sun Pharma Laboratories Ltd. operates as a pharmaceutical company. The company is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Sector
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.91% | 43.54B | |
| +16.96% | 21.74B | |
| +7.98% | 13.02B | |
| +6.43% | 13.53B | |
| +33.80% | 11.28B | |
| -11.05% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +7.71% | 5.09B | |
| +3.49% | 4.42B |
- Stock Market
- Equities
- SUNPHARMA Stock
- Company Sun Pharmaceutical Industries Ltd.
